Vascular endothelial growth factor

Feb 17, 2019

Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients

Feb 17, 2019

Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients

Jan 28, 2019

NMPA Accepts New Drug Application for IBI-305, a Biosimilar Product Candidate of Bevacizumab (Avastin®)

Dec 12, 2018

Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints

Oct 26, 2018

REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2018 Annual Meeting

Oct 11, 2018

Canadian Scientist Positioned to Advance Groundbreaking Treatment for Leading Cause of Vision Loss

Sep 05, 2017

The Angiogenesis Foundation Convenes National AMD Expert Summit: Improving Long-Term Patient Outcomes